Medicine shortages in Spain
Live register of drug shortage notices in Spain, aggregated daily from official regulator publications and linked back to every source.
Regulators list each strength and pack separately, so one medicine can carry several notices — compare official per-medicine tallies against “Medicines affected”. How we count
Latest shortage notices in Spain
| Medicine | Status | Severity | Since | Source |
|---|---|---|---|---|
| Acarbosa | active | medium | 5 Nov 2026 | AEMPS |
| Vildagliptina/Metformina Sandoz | active | medium | 5 Nov 2026 | AEMPS |
| Metoclopramida Kern Pharma | active | high | 5 Nov 2026 | AEMPS |
| Novothirteen | active | high | 5 Nov 2026 | AEMPS |
| Minoxidil | active |
Official sources for Spain
- Agencia Española de Medicamentos y Productos Sanitarios — Suministro (AEMPS) — official register · last checked 8 Nov 2026
- Spain Nomenclátor de facturación (SNS) (NOMEN-ES) — official register · last checked 25 Jun 2026
Frequently asked questions
How many medicines are in shortage in Spain?
Spain currently has 1458 active medicine shortage notices. Figures update daily from official regulator publications.
Who reports medicine shortages in Spain?
Official shortage notices for Spain are published by Agencia Española de Medicamentos y Productos Sanitarios — Suministro (AEMPS), Spain Nomenclátor de facturación (SNS) (NOMEN-ES). Mederti checks these sources daily and links every notice back to the original publication.
How current is this Spain shortage data?
Mederti scrapes Spain's official shortage register daily. Each notice carries the regulator's own dates; the list on this page reflects the most recent successful update.
Track Spain shortages that matter to you
Watchlists, email alerts, alternatives and cross-country comparison — free for individual pharmacists and clinicians.
Create a free accountData is aggregated from official sources and provided for information only. Mederti is not affiliated with or endorsed by any regulator. Verify with AEMPS before clinical or procurement decisions.